Dr. Zenovia Clear Complexion

Description

DR. ZENOVIA is a product formulated for hormonal dermatology, specifically designed to promote a clear complexion. The product consists of 10% glycolic acid and 2% salicylic acid, combined with the proprietary reg-ulate360 complex™. These components work synergistically to enhance exfoliation and facilitate skin renewal, while also addressing acne and minimizing scarring. Each package contains 60 pads, providing a convenient dosage form for application.

Uses and Indications

This drug is indicated for the treatment and management of acne. It penetrates the pores to eliminate most acne and blemishes, while also helping to prevent the development of new acne blemishes and blackheads.

Dosage and Administration

Healthcare professionals are advised to instruct patients to gently swipe the pad over a clean face, taking care to avoid the eye area. The product may be used once or twice daily, depending on the patient's skin tolerance and response. It is important to inform patients that a tingling sensation may occur during application, which is considered a normal reaction.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation occurs, it is recommended that patients limit their use to one acne medication at a time to mitigate adverse effects.

It is imperative to keep this product out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The use of this medication may lead to skin irritation and dryness, particularly if another topical acne medication is used concurrently. In such cases, it is advised to limit the use to one acne medication at a time to minimize the risk of irritation.

In the event of accidental ingestion, patients are urged to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Zenovia Clear Complexion (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be closely monitored to ensure that the product is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

This product is intended for external use only. Care should be taken to avoid application near the eye area. If the product inadvertently comes into contact with the eyes, it should be flushed with water, and if irritation persists, a physician should be consulted.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for safety in pregnant women. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. The use of salicylic acid during pregnancy may pose risks, and it is advised that pregnant patients consult a healthcare provider before use. Additionally, dosage adjustments may be necessary for pregnant individuals; therefore, healthcare professionals should be consulted for guidance regarding appropriate dosing in this population.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, it is important to inform patients that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. Patients should be counseled to use only one acne medication at a time to minimize the risk of irritation.

Storage and Handling

The product is supplied in configurations that ensure optimal use and safety. It is essential to cover areas to which the product has been applied with sunscreen prior to sun exposure to maintain effectiveness and protect the skin.

For storage, the product should be kept out of reach of children to prevent accidental ingestion or misuse. Specific temperature ranges and container requirements are not provided; however, general best practices for storage should be followed to ensure product integrity. Special handling needs include the precaution of applying sunscreen over treated areas before exposure to sunlight.

Additional Clinical Information

The product is administered topically, with a recommended frequency of once or twice daily. Clinicians should advise patients to cover treated areas with sunscreen prior to sun exposure to minimize potential adverse effects. In the event of contact with the eyes, patients should flush the area with water and seek medical attention if irritation persists.

Drug Information (PDF)

This file contains official product information for Dr. Zenovia Clear Complexion, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)